medigraphic.com
ISSN 1405-8871 (Print)

2020, Number 3

<< Back Next >>

Aten Fam 2020; 27 (3)

Irritable Bowel Syndrome: A Holistic Approach

Mendoza LG, Becerra TEC

Language: Spanish
References: 33
Page: 150-154
PDF size: 115.89 Kb.


ABSTRACT

Irritable bowel syndrome (ibs) is a chronic disease that affects gastrointestinal function and requires significant demand for medical care; its incidence increases depending on lifestyles and other comorbidities. Currently the therapeutic approach should be done comprehensively by carrying out adequate monitoring and treatment. The objective of this review is to make known the risk factors, symptomatology and treatment used for this syndrome, with the purpose of strengthening its multidisciplinary approach and improving the quality of life of patients.


REFERENCES

  1. Zhou S, Liu X, Wang X, Pharmacological and non-pharmacological treatments for irritable bowel syndrome: Protocol for a systematic review and network meta-analises. Medicine (Baltimore). 2019;98(30):e16446.

  2. Ghiasi F, Amra B, Sebghatollahi V, Azimian F. Association of irritable bowel syndrome and sleep apnea in patients referred to sleep laboratory. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2017;22.

  3. Qin D, Xue B, Chen M, Pharmacological treatments for patients with bowel syndrome: An umbrella review of systematic reviews and metaanalises. Medicine. 2019;98(32).

  4. Mei S, Wen YL, Hou HB, Effectiveness of vitamin D for irritable bowel syndrome: A protocol for a systematic review of randomized controlled trial. Medicine. 2019;98(9):e14723.

  5. Lopes S, Miszputen JS, Sachs A, Evaluation of carbohydrate and fiber consumption in patients with irritable bowel syndrome in outpatient treatment. Arq. Gastroenterol. 2019;56(1):3-9.

  6. Pittayanon R, Lau J, Yuan Y, Gut Microbiota in Patients With Irritable Bowel Syndrome- A Systematic Review. Gastroenterology. 2019;157:97- 108.

  7. Tack J, Stanghellini V, Mearin F. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European counties. BMC Gastroenterology. 2019;19(69):1-13.

  8. Grupo de trabajo de la guía de práctica clínica sobre el síndrome del intestino irritable. Manejo del paciente con síndrome del intestino irritable. Barcelona: Asociación Española de Gastroenterología, Sociedad Española de Familia y Comunitaria y Centro Cochrane Iberoamericano, 2005.

  9. Goldenberg JZ, Acero A, Day A. Naturopathic approaches to irritable bowel syndrome: protocol for a prospective observational study in academic teaching clinics. Integr Med Res. 2018;7(3):279- 286.

  10. Ghiasi F, Amra B, Sebghatollahi V. Association of irritable bowel syndrome and sleep apnea in patient referred to sleep laboratory. J. Res. Med. Sci. 2017;22:72.

  11. Larussa T, Rossi M, Suraci E. Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey. Medicina (Kaunas). 2019;55(2):46.

  12. O’ Mahony SM, Clarke G, Dinan TG. Irritable Bowel Syndrome and Stress-Related Psychiatric Co-morbidities: Focus on Early Life Stress. Handb Exp Pharmacol. 2017;239:246.

  13. Sehonou J, Dodo LR. Profil clinique et facteurs associés au syndrome de I’ntestin irritable chez les etudiants en medicine á Cotonou, Bénin. Pan Afr Med J. 2018;19(31):123.

  14. Williams CE, Williams EA, Corfe BM. Vitamin D status in irritable bowel syndrome and the im- pact of supplementation on symptoms: what do we know and what do we need to know. Eur J Clin Nutr. 2018;72(10):1358-63.

  15. Canicoba M, Nastasi V. La dieta reducida en FODMAP: ventajas y controversias. Nutr Clin Med. 2016;10(1):20-39.

  16. Barbalho SM, Goulart RA, Araújo AC. Irritable Bowel Syndrome: a review of the general aspects and the potential role of vitamin D. Expert Review of Gastroenterology and Hepatology. 2019;13(4):345-59.

  17. Xu D, Chen VL, Steiner CA. Efficacy of fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. J Gastroenterol. 2019;114(7):1043-50.

  18. Tu Q, Heitkemper MM, Jarret ME. Sleep Disturbances in Irritable Bowel Syndrome: a systematic review. WILEY NGM. 2016.

  19. Sadeghian M, Sadeghi O, Keshteli AH, Physical activity in relation to irritable bowel syndrome among Iranian adults. PLoS One. 2018;13(10).

  20. Domingo JJ. Los nuevos criterios de Roma (IV) de los trastornos funcionales digestivos en la práctica clínica. Med Clin. 2017;148(10):464-468.

  21. Simrén M, Tomblom H, Palsson O. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome. Gastroenterology. 2019;157(2):391-402.

  22. Diagnóstico y Tratamiento del Intestino Irritable en el Adulto. México: Secretaría de Salud; 2015. [Internet]. [Citado 2019 Sep 15] Disponible en: http://www.cenetec.salud.gob.mx/interior/catalogoMaestroGPC. html

  23. Laird KT, Tanner E, Rusell A. Comparative efficacy of psychological therapies for improving mental health and daily functioning in irritable bowel syndrome: A systematic review and meta-analysis. Clinical Psychology Review. 2017;51:142-152.

  24. Casellas F. Burgos R. Marcos A. Consensus documento on exclusión diets in irritable bowel sindrome (IBS) Nutr Hosp. 2018:35(6):1450-66.

  25. Heavey E, Eileen D. Limitig FODMAP consumption for patients with IBS. Nursing. 2018;48(11):54-7.

  26. Frieling T, Heise J, Krumen B, Hundorf C. Tolerability the FODMAP reduced diet in irritable bowel syndrome efficacy-adherence and body weight course. Gastroenterol. 2019;57(6):740-44.

  27. Mari A, Hosadurg D, Martin L. Adherence with a low FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?. Eur J Gastroenterol Hepatol. 2019;31(2):178-82.

  28. Zhang FM, Li S, Ding L. Effectiveness of mesalazine to treat irritable bowel syndrome. Medicine. 2019;98:28.

  29. Alammar N, Wang L, Saberi B. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. BMC Complement Altern Med. 2019;19(1):21. doi: 10.1186/s12906-018-2409-0.

  30. Liang D, Longgui N, Guoqiang X. Efficacy of different probiotic protocols in irritable bowel syndrome A network meta-analysis. Medicine. 2019;98:27.

  31. Wilson B, Rossi M, Dimidi E. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition. 2019;109(4):1098-11.

  32. Eales J, Gibson P, Whorwell P. Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM 1-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. Therap Adv Gastroenterol. 2017;10(1):74-88.

  33. Munjal A. Dedania B. Cash B. Update on Pharmacotherapy for Irritable Bowel Syndrome. Curr Gastroenterol Rep. 2019;21(6):25.




2020     |     www.medigraphic.com